HUMIRA® (adalimumab) Pen
The HUMIRA Pen has one touch activation and easy-to-grip shape for patients with stiffness in the hands.
(adalimumab), an FDA approved treatment for moderate to severe rheumatoid arthritis (RA) and psoriatic arthritis (PsA) created by Abbott. With its one-touch activation and easy-to-grip size and shape, the HUMIRA® Pen offers improved ease of use for these patients, many of whom may have swelling or stiffness in the hands.
The HUMIRA® Pen is a single-use pen containing a 1 mL prefilled glass syringe with a fixed 27 gauge 1/2 inch needle, providing 40 mg (0.8 mL) of HUMIRA. Talk with your doctor about the HUMIRA® Pen and the HUMIRA® prefilled syringe.
Ease of Use Program
Products proven to make life easier
Learn more about the extensive testing these products go through as well as tips for selecting easy-to-use products.
The Arthritis Foundation's Ease of Use Commendation Program recognizes products proven to make life easier for people who have arthritis and other physical limitations. Independently tested by experts and evaluated by people with arthritis, Ease of Use products are easy to use for everyone.
Stay in the Know. Live in the Yes.
Get involved with the arthritis community. Tell us a little about yourself and, based on your interests, you’ll receive emails packed with the latest information and resources to live your best life and connect with others.